<DOC>
	<DOCNO>NCT01843569</DOCNO>
	<brief_summary>We hypothesize combination natural cycle IVF low dose gonadotropin injection combine In Vitro Maturation ( IVM ) ( Natural IVF/IVM ) viable option select population infertility patient tolerate exogenous gonadotropin risk ovarian hyperstimulation syndrome .</brief_summary>
	<brief_title>In Vitro Maturation ( IVM ) Human Oocytes</brief_title>
	<detailed_description>Natural IVF/IVM may attractive treatment alternative conventional control ovarian hyperstimulation ( COH ) /IVF treatment infertile woman particular select group . Natural IVF/IVM offer several advantage conventional COH protocol IVF include : 1 . Elimination need gonadotropin ovarian stimulation 2 . Elimination risk develop OHSS 3 . Simplification treatment , eliminate need frequent blood test ultrasound monitor 4 . Reduced cost treatment 5 . Avoiding potential side effect gonadotropin , include weight gain , bloating , breast tenderness , nausea , mood swing 6 . Eliminates concern potential risk malignancy may associate multiple cycle ovarian stimulation predispose population . This pilot study conduct assess clinical efficacy natural IVF/IVM</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<criteria>1 . Each subject must female . 2 . Each subject must indication COH IVF ICSI . 3 . Each subject must willing able provide write informed consent trial . 4 . Each subject must â‰¤42 year age time sign informed consent . 5 . Each subject must normal cervical smear result ( atypical abnormal cell , case atypical squamous glandular cell , sign malignancy ; correspond Papanicolaou [ PAP ] I II ) obtain within 12 month prior sign informed consent must available . 1 . Subject premature ovarian failure . 2 . Subject endocrine abnormality hyperprolactinaemia thyroid dysfunction . 3 . Subject malformation absence uterus . 4 . Subject test positive Human Immunodeficiency Virus ( HIV ) Hepatitis B ( local laboratory ; result obtain within 1 year prior sign ICF consider valid ) . 5 . Subject contraindication allergy/hypersensitivity hCG , estrogen progesterone .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>In Vitro Maturation</keyword>
	<keyword>IVM</keyword>
	<keyword>Natural cycle IVF</keyword>
	<keyword>PCOS</keyword>
</DOC>